Mascarenhas, J. O., Talpaz, M., Gupta, V., Foltz, L. M., Savona, M. R., Paquette, R., Turner, A. R., Coughlin, P., Winton, E., Burn, T. C., O’Neill, P., Clark, J., Hunter, D., Assad, A., Hoffman, R. and Verstovsek, S. (2017) “Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosis”, Haematologica. Pavia, Italy, 102(2), pp. 327-335. doi: 10.3324/haematol.2016.151126.